Stock Under $10 with 50-100% upside potential - 14 Days FREE!

5 Stocks Under $10 Set to Trade Higher in November

Stock quotes in this article: AIQ, ARWR, ANTH, RIMM, EDMC, AERL 

Anthera Pharmaceuticals

One under-$10 name in the biotechnology and drugs complex that's moving within range of triggering a near-term breakout trade is Anthera Pharmaceuticals (ANTH). This company is focusing on developing and commercializing products to treat serious diseases associated with inflammation, including cardiovascular and autoimmune diseases. This stock has been destroyed by the bears so far in 2012, with shares down by over 80%.

If you take a look at the chart for Anthera Pharmaceuticals, you'll that this stock has been trending sideways for the last two months, with shares moving between 81 cents on the downside and $1.29 on the upside. Shares of ANTH have just today started to challenge its 50-day at 98 cents per share, and it's quickly moving within range of triggering a major breakout trade above some near-term overhead resistance levels.

Traders should now look for long-biased trades in ANTH once it manages to break out above some near-term overhead resistance levels at $1.07 to $1.29 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 1,130,750 shares. If that breakout triggers soon, then ANTH will set up for a potentially explosive move higher back towards its next major overhead resistance level at $1.79 a share. Any high-volume move above $1.79 will give ANTH a chance to re-fill some of its previous gap down zone that started at around $2.80 a share.

Traders can look to buy ANTH as long as it's trending above today's low of 95 cents per share with strong upside volume flows. You can also buy off strength once ANTH takes out $1.07 to $1.29 a share with volume, and then simply use a stop that sits just below its 50-day at 98 cents per share.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
TRY IT FREE

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Dividend Stock Advisor
TRY IT FREE
New! $49.95/yr

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREE

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Real Money
TRY IT FREE

24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.

Product Features:
  • Jim Cramer + 20 Wall Street pros
  • Intraday commentary & news
  • Real-time trading forum
  • Actionable trade ideas
Real Money Pro
TRY IT FREE

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass + 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
TRY IT FREE

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
DOW 15,294.50 -12.67 -0.08%
NASDAQ 3,459.42 -3.88 -0.11%
S&P 500 1,650.51 -4.84 -0.29%
US 10 Yr 2.000% -0.023

Brokerage Partners

Advertising Partners
Special Features

Free Newsletters from TheStreet

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

We respect your privacy. Manage Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs